FENOFIBRON 145 provides an insightful exploration of Fenofibrate, particularly in its 145mg formulation, shedding light on its uses, dosage, side effects, price, composition, and more. Fenofibrate stands as a cornerstone in the management of dyslipidemia, offering a comprehensive approach to reducing cardiovascular risk factors and enhancing patient outcomes. Uses: Fenofibrate 145mg plays a crucial role in managing dyslipidemia, a condition characterized by abnormal lipid levels such as elevated triglycerides and/or low levels of high-density lipoprotein cholesterol (HDL-C). By activating peroxisome proliferator-activated receptor alpha (PPARα), Fenofibrate modulates lipid metabolism, reducing triglyceride synthesis, and enhancing the clearance of triglyceride-rich lipoproteins. Additionally, Fenofibrate promotes HDL-C synthesis and facilitates the conversion of small, dense LDL-C particles into larger, less atherogenic particles, thereby mitigating cardiovascular risk. Dosage: The recommended dosage of Fenofibrate 145mg is tailored to individual patient needs, considering factors such as lipid profile, cardiovascular risk factors, and concurrent medications. Typically administered orally once daily, preferably with meals, Fenofibrate 145mg optimizes therapeutic efficacy while minimizing gastrointestinal side effects. Healthcare providers meticulously titrate the dosage to achieve optimal lipid control and reduce the risk of cardiovascular events, often in conjunction with lifestyle modifications and other lipid-lowering agents. Side Effects: While generally well-tolerated, Fenofibrate 145mg may evoke adverse effects in some individuals. Common side effects include gastrointestinal disturbances (e.g., abdominal pain, nausea, diarrhea), headache, myalgia, and rash. These side effects are usually mild and transient, resolving with continued therapy or dosage adjustments. Rare but serious adverse effects may include pancreatitis, myopathy (with or without rhabdomyolysis), and liver dysfunction. Patients experiencing symptoms suggestive of pancreatitis (e.g., severe abdominal pain, nausea, vomiting) or myopathy (e.g., unexplained muscle pain, weakness) should promptly seek medical attention.A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  For further information:  EMAIL:  info@sterispharma.com  / contact@sterispharma.com     CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668